News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

Global Cell Therapeutics (GBT) Illumina (ILMN) Elan (ELN) Human Genome Sciences (HGSI) Amgen (AMGN) Intrexon (XON) Anadys (ANDS) Benlysta (belimumab) Multiple Myeloma Vitae Pharmaceuticals (VTAE) Sequenom (SQNM) Sangamo (SGMO) SUNESIS PHARMACEUTICALS (SNSS) VANDA (VNDA) KERYX (KERX) ISIS (ISIS) GUARDIAN HEALTH Galena (GALE) C4 Therapeutics Theravance (THRX) SYNTA (SNTA) Ridaforolimus ADVENTRIX (ANX) Jazz Pharmaceuticals (JAZZ) Agenus (AGEN) Incyte (INCY) Ionis (IONS) Dendreon (DNDN) REGULUS (RGLS) ZALTRAP™ Sanofi (SNY) AGOS (ARGS) Telaprevir Xoma (XOMA) Valeant Pharmaceuticals International (VRX) TOKAI (TKAOI) Inovio (INO) Biogen Idec (BIIB) JUNO (JUNO) Sarepta (SRPT) Intercept (ICPT) Trastuzumab-DM1 Ariad (ARIA) Herceptin INNOVIVA (INVA) Human Longevity (HLI) Spike Therapeutics (ONCE) GlaxoSmithKline (GSK) HALOZYME (HALO) Sanofi-Aventis (SAN) ARCA (ABIO) ACADIA (ACAD) Gilead (GILD) Intermune (ITMN) Array Pharmaceuticals (ARRY) PTC Therapeutics (PTCT) Zerenex Vertex (VRTX) Sanofi (SNA) Exelixis (EXEL) OSI (OSIP) IDERA (IDRA) Editas (EDIT) Idenix (IDIX) Rapamune Onyx (ONXX) ABBVIE (ABBV) NEKTAR (NKTR)) Agenus (AGEN Biocryst (BCRX) KITE (KITE) CompuGen (CGEN) Dynavax (DVAX) Cytokinetics (CYTK) Alder Biopharmaceuticals (ALDR) Micromet (MITI) Alnylam (ALNY) AERIE PHARMACEUTICALS Pluristem (PSTI) Roche (ROCHE) NANTKWEST (NK) RenenxBio (RGNX) ARGOS (ARGS) Merck (MRK) Roche (RHHBY) Regeneron (REGN) SERES THERAPEUTICS (MCRB) Ziofpharm (ZIOP) ImmunoGen (IMGN) Genentech Bristol-Myers Squibb (BMY) BIOMARIN (BMRN) Anacor (ANAC) Aimmune Therapeutics (AIMT) Theravance Bio Pharma (TBPH) Abbott Laboratories (ABT) Tysabri Velcade (bortezomib) Prosensa (RNA) Auspex (ASPX) Mirati Therapeutics (MRTX) Endometrial Cancer Seattle Genetics (SGEN) Revlimid (lenolidamide) galapagos (GLPG) Prolor Biotech (PBTH)